Family Medicine, Sleep Medicine · Shreveport, LA
NPI
1437446341
Since 2011
Specialty
Family Medicine, Sleep Medicine
Code 207QS1201X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
7600 Fern Ave Ste 700a
Shreveport, LA, 71105
Phone (318) 657-0187
Groups this clinician bills Medicare through
Medicare paid, 2024
$102K
895 services
Medicare patients, 2024
287
Average age 71
Drug cost, 2024
$801K
701 prescriptions
Company payments, 2025
$2,938
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sara Munjampalli was code 99214 (office e&m - established), 452 times for 211 patients. In total Sara Munjampalli billed 895 services in 12 codes, and Medicare paid $102K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-05-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 452 | 211 | $86.07 | $39K |
| 95800 Sleep Study | Office | 140 | 134 | $69.12 | $9,677 |
| 99204 Office E&M - New | Office | 88 | 88 | $114.89 | $10K |
| 99213 Office E&M - Established | Office | 66 | 51 | $61.18 | $4,038 |
| 95811 Sleep Study | Office | 59 | 53 | $449.83 | $27K |
| 95976 Electrical Nerve Conductivity | Office | 41 | 14 | $27.07 | $1,110 |
| 95810 Sleep Study | Office | 24 | 22 | $438.50 | $11K |
By year: 2022 $129K for 951 services; 2023 $104K for 1,148 services; 2024 $102K for 895 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sara Munjampalli prescribed most often to Medicare patients was Zolpidem Tartrate, with 156 prescriptions and refills. In total Sara Munjampalli wrote 701 Medicare prescriptions that cost $801K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Zolpidem Tartrate Generic | 156 | 172 | 37 | $573 |
| Eszopiclone Generic | 52 | 66 | 11 | $505 |
| Modafinil Generic | 44 | 53 | Under 11 | $2,503 |
| Clonazepam Generic | 36 | 36 | Under 11 | $93.2 |
| Wakix Pitolisant Hcl | 36 | 36 | Under 11 | $503K |
| Trazodone Hcl Generic | 35 | 50 | Under 11 | $98.94 |
| Sunosi Solriamfetol Hcl | 32 | 48 | Under 11 | $41K |
| Buspirone Hcl Generic | 26 | 56 | Under 11 | $379 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 25 | 33 | Under 11 | $868 |
| Doxepin Hcl Generic | 22 | 28 | Under 11 | $306 |
| Mirtazapine Generic | 19 | 35 | Under 11 | $188 |
| Temazepam Generic | 18 | 18 | Under 11 | $301 |
| Ropinirole Hcl Generic | 13 | 35 | Under 11 | $92.1 |
| Zolpidem Tartrate Er Zolpidem Tartrate | 11 | 15 | Under 11 | $1,029 |
| Cyclobenzaprine Hcl Generic | 11 | 23 | Under 11 | $74.19 |
Brand drugs: 111 claims; generic drugs: 590 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sara Munjampalli $2,938 ($2,938 in general payments such as food, travel and fees) from 9 companies. The largest payer was Inspire Medical Systems, Inc. with $1,087.
| Company | Payments | Amount |
|---|---|---|
| Inspire Medical Systems, Inc. INSP | 31 | $1,087 |
| Jazz Pharmaceuticals Inc. JAZZ | 10 | $549 |
| Axsome Therapeutics, Inc. AXSM | 11 | $404 |
| Harmony Biosciences LLC HRMY | 13 | $271 |
| Itamar Medical Inc | 1 | $266 |
| Avadel CNS Pharmaceuticals, LLC | 3 | $265 |
| ZOLL Respicardia, Inc. | 2 | $54.94 |
| Idorsia Pharmaceuticals US Inc | 1 | $24.69 |
| Lilly USA, LLC LLY | 1 | $15.94 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.